Patient Testimonials

Non-Small Cell Lung Cancer

A combination of world-class advice and the data from the mice is ensuring that my oncologist has far more information about the potential effectiveness of various treatments than would normally be the case. I feel more in control and not a passive victim of my condition."

- London, UK

Sarcoma

Champions Oncology has given my family hope and strength. My husband finally has a fighting chance to beat the odds and survive his cancer. The physicians, coordinators, and entire staff at Champions have been extremely professional, caring, approachable, accessible, and very kind. As a wife, I will always be indebted to Champions for helping save my husband’s life. As a physician, I intend to help this phenomenal company make cancer a thing of the past! [Testimonial from Spouse]

- Toronto, Canada

Metastatic Colon Cancer

I’ve been to quite a few doctors in quite a few states and trying to find someone that could help me more than tell me to go home and take a chemotherapy and basically good luck. I can’t accept that — I’m a single mom, I’m 44 years old — I am not going to accept that answer. [After working with Champions] I’m so grateful that I can be with friends, my family, my son. It’s just been a really miraculous experience."

- Alabama, US

Adenoid Cystic Carcinoma of Submandibular Gland

Thanks to Champions, I am treated now with Temodor, which seems to be very efficient. I cannot imagine how the physicians would come up with this solution using the conventional ways."

- Israel

Individual outcomes may vary.

References:

  1. Hidalgo M et al. Activity of gemcitabine in direct patient derived xenografts predicts clinical outcome: validation of an in vivo model for drug development. J Clin Oncol 27:15s, 2009 (suppl; abstr 4528)
  2. Hidalgo M et al. A Pilot Study of Treatment Guided by Personalized Tumorgrafts in Patients with Advanced Cancer. Mol Cancer Ther August 2011 10:1311-1316
  3. Rubio-Viqueira B, Jimeno A, Cusatis G, et al. An in vivo platform for translational drug development in pancreatic cancer. Clin Cancer Res. 2006;12:4652-4661.
  4. Champions data on file.